Neurology News and Research

Latest Neurology News and Research

Researchers use experimental PET to detect abnormal tau in brains of living former NFL players

Using an experimental positron emission tomography scan, researchers have found elevated amounts of abnormal tau protein in brain regions players with cognitive, mood and behavior symptoms.

11 Apr 2019

New strategy for editing and repairing genetic mutation associated with microduplications

Scientists at UMass Medical School have developed a strategy for editing and repairing a particular type of genetic mutation associated with microduplications using CRISPR/Cas9 and a seldom-used DNA repair pathway.

11 Apr 2019

Scientists develop technique to clear abnormal tau protein from human neurons

Harnessing a probe used to image the brain in diagnosing Alzheimer's disease and related forms of dementia, scientists at Dana-Farber Cancer Institute and Massachusetts General Hospital have successfully cleared patient-derived brain cells of an abnormal protein associated with dementia and other neurogenerative disorders.

10 Apr 2019

Understanding imbalance in key neural pathway to help treat psychiatric disorders

Researchers at the University of California, Irvine have identified for the first time an imbalance in a key neural pathway that explains how some people reactivate negative emotional memories.

10 Apr 2019

Early nutritional intervention can help fight dementia

Trials have revealed significant advantages for patients who are treated with daily medical nutrient drinks, with 45 % less deterioration in the Clinical Dementia Rating Sum of Boxes.

9 Apr 2019

Brain zaps at 60 could make the brain younger finds study

A new study has shown that zapping the brains of people over the age of 60 can help improve their memory and cognitive functions to function as if they were in their 20s.

8 Apr 2019

Advances in deep brain stimulation for Parkinson’s could lead to treatments for other disorders

A new paper published in Nature Reviews Neurology suggests that recent advances in deep brain stimulation for Parkinson disease could lead to treatments for conditions such as obsessive-compulsive disorder, Gilles de la Tourette syndrome and depression.

8 Apr 2019

Study of MS patients shows 18% were given wrong diagnoses

A recent study found that nearly 18 percent of patients diagnosed with multiple sclerosis before being referred to two major Los Angeles medical centers for treatment actually had been misdiagnosed with the autoimmune disease.

8 Apr 2019

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

Researchers have known for decades that inflammation accompanies Alzheimer's disease brain lesions. Several early studies suggested that "super-aspirins" or Nonsteroidal anti-inflammatory drugs could help avoid the disease.

8 Apr 2019

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

Researchers have known for decades that inflammation accompanies Alzheimer's disease (AD) brain lesions.

5 Apr 2019

Vascular changes in the eye reveal early cognitive impairment

Reduced blood capillaries in the back of the eye may be a new, noninvasive way to diagnose early cognitive impairment, the precursor to Alzheimer's disease in which individuals become forgetful, reports a newly published Northwestern Medicine study.

5 Apr 2019

New Research Unit funded by DFG aims to improve diagnosis of genetic diseases

How can we improve the identification and prompt diagnosis of genetic diseases? A new Research Unit at Charité - Universitätsmedizin Berlin will set out to identify and reliably interpret important non-coding sections of our genomes in the hope of finding the diagnosis for unsolved diseases.

5 Apr 2019

PET images of microglial activation levels could better predict Alzheimer's disease progression

Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.

4 Apr 2019

$Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy$

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.

4 Apr 2019

Mutation in Huntington’s disease may alter interactions of Huntingtin protein with Rac1

Since 1993, when the gene that causes Huntington's disease was identified, there has been intense focus on understanding how this genetic mutation causes the disease's severe progressive neural deterioration.

4 Apr 2019

PET scans could be used to develop best practices for dementia

The application of positron emission tomography (PET) for amyloid plaques could aid clinical decision making for patients with dementia or mild cognitive impairment (MCI).

3 Apr 2019

New guidance on use of valproate in women, girls of child bearing age with epilepsy published

New guidance to support regulations around the use of valproate in women and girls of child bearing age with epilepsy has been published by specialists from 13 UK healthcare bodies including seven Royal Colleges.

2 Apr 2019

New Hasso Plattner Institute for Digital Health launched at Mount Sinai

The Mount Sinai Health System and the Hasso Plattner Institute today announced an affiliation that brings together industry leaders with combined expertise in health care delivery, health sciences, biomedical and digital engineering, machine learning and artificial intelligence to rapidly develop digital health products with real-time predictive and preventive capabilities that empower patients and health care providers, and improve health and health outcomes.

29 Mar 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019

Quanterix appoints Amol Chaubal as Chief Financial Officer

Quanterix announced that it has named Amol Chaubal to the position of Chief Financial Officer, effective April 12, 2019.

From Quanterix 28 Mar 2019

Neurology News and Research

Latest Neurology News and Research

Researchers use experimental PET to detect abnormal tau in brains of living former NFL players

New strategy for editing and repairing genetic mutation associated with microduplications

Scientists develop technique to clear abnormal tau protein from human neurons

Understanding imbalance in key neural pathway to help treat psychiatric disorders

Early nutritional intervention can help fight dementia

Brain zaps at 60 could make the brain younger finds study

Advances in deep brain stimulation for Parkinson’s could lead to treatments for other disorders

Study of MS patients shows 18% were given wrong diagnoses

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

Vascular changes in the eye reveal early cognitive impairment

New Research Unit funded by DFG aims to improve diagnosis of genetic diseases

PET images of microglial activation levels could better predict Alzheimer's disease progression

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

Mutation in Huntington’s disease may alter interactions of Huntingtin protein with Rac1

PET scans could be used to develop best practices for dementia

New guidance on use of valproate in women, girls of child bearing age with epilepsy published

New Hasso Plattner Institute for Digital Health launched at Mount Sinai

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

Quanterix appoints Amol Chaubal as Chief Financial Officer

Aneuro: Advancing Neuroscience Research eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Neurology News and Research

Latest Neurology News and Research

Aneuro: Advancing Neuroscience Research eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in